Clinical outcome between familial and sporadic origin for MSI colon cancer patients treated with adjuvant FOLFOX +/- cetuximab: A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials

ANNÉE

2019

AUTEURS

Zaanan A, Shi Q, Taieb J, Alberts S, Meyers J, Smyrk T, Julié C, Zawadi A, Tabernero J, Mini E, Goldberg R, Folprecht G, Laethem J, Le Malicot K, Sargent D, Laurent-Puig P, Sinicrope FA

CONGRÈS/REVUE

JCO Precision Oncology

LIEN PUBLICATIONS ASSOCIÉES